产品特点
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Enrotab 15 mg tablets for cats and dogs
Enrotab Vet. (DK)
Enrotab Vet. 15 mg tablets for cats and dogs (SE, NO,
FI)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCE:
Enrofloxacin
15.0 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet
A slightly yellow, round, convex snap-tab tablet for oral administration to
dogs and cats.
The tablet can be divided into equal halves.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs and cats
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In cats:
treatment of upper respiratory tract infections
In dogs:
- treatment of lower urinary tract infections (associated or not with prostatitis) and upper
urinary tract infections caused by Escherichia coli or Proteus mirabilis.
- Treatment of superficial and deep pyoderma.
4.3
CONTRAINDICATIONS
Do not use in young or growing dogs (dogs aged less than 12 months (small breed) or less
than 18 months (large breed)) as the product may cause epiphyseal cartilage alterations in
growing puppies.
Do not use in young, growing cats, because of the possibility of the development of cartilage
lesions. (cats aged less than 3
months or weighing less than 1kg).
Do not use in cats or dogs having seizure disorders, since enrofloxacin may cause CNS
stimulation.
Do not use in cats or dogs with known hyp
阅读完整的文件
产品特点 